Article 13 Feb 2024 FDA's Office Of Prescription Drug Promotion Issues Its First Untitled Letter Of The Year To Novartis For Misleading Statement Relating To KISQALI® United States Healthcare
Article 20 Oct 2022 California Passes First State Law Requiring Physicians To Disclose Open Payments Database To Patients United States Healthcare
Article 31 Aug 2022 Charging For Investigational Drugs Under An IND Questions And Answers, Draft Guidance For Industry, August 2022 United States Healthcare
Article 20 May 2022 FDA White Paper Signals Shift To Performance-Based Reviews Of Mature Quality Systems United States Healthcare
Article 20 Apr 2022 FDA Issues Untitled Letter To Bausch Health Companies For Misleading Statements Relating To DUOBRII™ United States Healthcare